Gerard Tobin
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 36
-
- Lymphoma Diagnosis and Treatment 21
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 22
- Physiology top 5%
- Telomeres, Telomerase, and Senescence 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Cardiac Imaging and Diagnostics 2
-
- Glycosylation and Glycoproteins Research 5
- PI3K/AKT/mTOR signaling in cancer 4
Gerard Tobin
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 84
- Genetics 1.4k
- Pathology and Forensic Medicine 1.0k
- Immunology 969
- Physiology 82
- Radiology, Nuclear Medicine and Imaging 379
Countries citing papers authored by Gerard Tobin
This map shows the geographic impact of Gerard Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Tobin more than expected).
Fields of papers citing papers by Gerard Tobin
This network shows the impact of papers produced by Gerard Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Tobin. The network helps show where Gerard Tobin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gerard Tobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | prognosis in chronic lymphocytic leukemia CD38 expression is a poor predictor for VH gene mutational status and | 2013 | 1 |
| 2 | 2012 | 19 | |
| 3 | 2009 | 30 | |
| 4 | 2008 | 18 | |
| 5 | 2007 | 6 | |
| 6 | 2007 | 25 | |
| 7 | 2007 | 44 | |
| 8 | 2007 | 11 | |
| 9 | 2005 | 3 | |
| 10 | 2005 | 18 | |
| 11 | 2005 | 10 | |
| 12 | 2005 | 11 | |
| 13 | 2005 | 90 | |
| 14 | 2004 | 199 | |
| 15 | 2004 | 30 | |
| 16 | 2003 | 16 | |
| 17 | 2003 | 43 | |
| 18 | 2003 | 29 | |
| 19 | 2003 | 19 | |
| 20 | V(a)3-21 gene utilizing chronic lymphocytic leukemias display restricted V lambda 2-14 gene usage and homologous CDR3s. | 2002 | 4 |
About Gerard Tobin
Gerard Tobin is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (36 papers), Immunodeficiency and Autoimmune Disorders (22 papers), Lymphoma Diagnosis and Treatment (21 papers), Glycosylation and Glycoproteins Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Telomeres, Telomerase, and Senescence (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cardiac Imaging and Diagnostics (2 papers). The work is most often cited by research in Genetics (1.4k citations), Pathology and Forensic Medicine (1.0k citations) and Immunology (969 citations). Gerard Tobin has collaborated with scholars based in Sweden, Finland and United Kingdom. Frequent co-authors include Richard Rosenquist, Ulf Thunberg, Christer Sundström, Göran Roos, Ola Söderberg, Anna Johnson, Gunilla Enblad, Karin Karlsson, Magnus Hultdin and Juhani Vilpo. Their work appears in journals such as Blood, European Journal Of Haematology, British Journal of Cancer, Leukemia and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.